12 reports of this reaction
1.3% of all BUTENAFINE HYDROCHLORIDE reports
#13 most reported adverse reaction
BURNING SENSATION is the #13 most commonly reported adverse reaction for BUTENAFINE HYDROCHLORIDE, manufactured by Bayer Healthcare LLC.. There are 12 FDA adverse event reports linking BUTENAFINE HYDROCHLORIDE to BURNING SENSATION. This represents approximately 1.3% of all 901 adverse event reports for this drug.
Patients taking BUTENAFINE HYDROCHLORIDE who experience burning sensation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BURNING SENSATION is a less commonly reported adverse event for BUTENAFINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to burning sensation, the following adverse reactions have been reported for BUTENAFINE HYDROCHLORIDE:
The following drugs have also been linked to burning sensation in FDA adverse event reports:
BURNING SENSATION has been reported as an adverse event in 12 FDA reports for BUTENAFINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BURNING SENSATION accounts for approximately 1.3% of all adverse event reports for BUTENAFINE HYDROCHLORIDE, making it a notable side effect.
If you experience burning sensation while taking BUTENAFINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.